1. Crawford L (2002) New drug and biological drug products; Evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible., vol 21 CFR parts 314 and 601, FDA, HHS; ACTION: Final Rule, 105 edn. Federal Register
2. Lushbaugh C (1969) Reflections on some recent progress in human radiobiology. In: Augenstein L, Mason R, Zelle M (eds) Advances in radiation biology. Academic, New York, p 277
3. Vriesendorp H, Van Bekkum D (1984) Susceptibility to total-body irradiation. In: Broerse J, MacVittie T (eds) Response of different species to total body irradiaton. Martinus Nijhoff, Amsterdam
4. Dainiak N (2002) Hematologic consequences of exposure to ionizing radiation. Exp Hematol 30:513–528
5. Anno GH, Young RW, Bloom RM, Mercier JR (2003) Dose response relationships for acute ionizing-radiation lethality. Health Phys 84:565–575